Ingenus Pharmaceuticals
As COO of Ingenus, Dr. Mehta is responsible for strategic and operational leadership for the growth of the company. Prior to joining Ingenus, Dr. Mehta was the President of Accord Healthcare, USA where he was responsible for the company’s inception, growth and management. Dr. Mehta brings over 16 years of pharmaceutical experience in overseeing such diverse areas as Hatch Waxman litigation, generic pharmaceutical sales, and marketing and pharmaceutical product development and registration.
Dr. Mehta earned his PhD in Pharmaceutical Sciences from the University of Georgia.
This person is not in any offices
Ingenus Pharmaceuticals
1 followers
Ingenus Pharmaceuticals is an emerging privately held U.S. based generic pharmaceutical company with manufacturing and research and development facilities in the U.S.,Switzerland, and India. Since 2010, Ingenus has been developing, manufacturing and commercializing quality generic medications as cost effective solutions for patients and suppliers. With over 65 filings covering a wide range of therapeutic classes ,including transdermal, parenteral, semi-solids, injectable, and extended release products Ingenus is well positioned to becoming a leader in the generic pharmaceutical industry.